Leucid Bio at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
Leucid Bio takes part in 2 sessions at Cell 2026 in London, its home city. Its sessions cover where cell and gene therapies fit in the wider biotech and treatment landscape. The specific focus is new ways to make CAR-T cells work better against solid tumours.
| Organization | Cell 2026 Attendance |
|---|---|
Leucid Bio London, UK | |
Develops CAR-T cell therapies for solid tumours using its Lateral CAR platform, with a lead programme targeting NKG2D ligands. | Panel Fri Nov 13 4:40pm–5:05pm Talk Fri Nov 13 5:30pm–5:55pm Novel Strategies To Enhance CAR T-Cell Function In Solid Tumours Cell and gene therapy |
Instantly find 20 buyers from Leucid Bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction